SCHOTT Pharma AG & Co. KGaA Stock
Equities
1SXP
DE000A3ENQ51
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
After market 03:56:50 pm | |||
30.22 EUR | -1.31% | 30.26 | +0.13% |
09:29am | SCHOTT PHARMA : Berenberg reiterates its Neutral rating | ZD |
May. 21 | Deutsche Bank Research lowers target for Schott Pharma - 'Buy' | DP |
Sales 2024 * | 977M 1.06B | Sales 2025 * | 1.11B 1.21B | Capitalization | 4.61B 5.01B |
---|---|---|---|---|---|
Net income 2024 * | 146M 159M | Net income 2025 * | 172M 187M | EV / Sales 2024 * | 4.92 x |
Net Debt 2024 * | 199M 217M | Net Debt 2025 * | 187M 204M | EV / Sales 2025 * | 4.33 x |
P/E ratio 2024 * |
31.3
x | P/E ratio 2025 * |
27.1
x | Employees | 4,687 |
Yield 2024 * |
0.52% | Yield 2025 * |
0.61% | Free-Float | 19.7% |
1 day | +0.23% | ||
Current month | -21.77% | ||
1 month | -23.10% | ||
3 months | -22.32% | ||
6 months | +6.07% | ||
Current year | -8.45% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Reisse
CEO | Chief Executive Officer | 63 | 22-06-30 |
Director of Finance/CFO | 43 | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eva Kienle
BRD | Director/Board Member | 57 | 23-04-03 |
Wolfgang Wienand
BRD | Director/Board Member | 52 | 23-04-03 |
Chairman | 59 | 23-04-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 30.22 | -1.31% | 42 486 |
24-05-27 | 30.62 | +0.46% | 18,265 |
24-05-24 | 30.48 | -0.39% | 29,588 |
24-05-23 | 30.6 | +0.59% | 25,205 |
24-05-22 | 30.42 | -1.11% | 36,133 |
Delayed Quote Xetra, May 28, 2024 at 03:18 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.45% | 5.01B | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.11B | |
+3.49% | 40.74B | |
+21.98% | 31.6B | |
+16.38% | 25.56B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- 1SXP Stock